Harrow Health Inc (NASDAQ: HROW) stock closed at $26.98 on 3/18/25 after a major increase of 15.7%. Moreover, trading volume in this advance was exceptionally high at 521% of normal. The stock has risen 21.4% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Harrow Health has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. Harrow Health has a neutral Power Rating of 43 but a poor Appreciation Score of 27, producing the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment